Skip to content

Agnès Emans Normal 0 21 false false false IT X-NONE X-NONE Normal 0 21 false false false IT X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Tableau Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:IT; mso-fareast-language:EN-US;}

MS - IE CNRS

Agnès EMANS received her Master degree in Cancerology from Paul Sabatier University Toulouse III in 2020. She joined the laboratory RESTORE in 2021 within PICSTEM (Production Industrielle de Cellules Souches issues de Tissu Adipeux) project concerning cell engineering and regenerative medicine. She is studying cells obtained from human adbominal dermolipectomy to set up predictive tests for therapeutic efficacy.

Coordonnées